默克雪兰诺有限公司
Merck KGaA, Darmstadt, Germany (Chinese subsidiary: 默克雪兰诺有限公司) is a 1668-founded German science and technology company operating across Life Science (tools/services), Healthcare (pharmaceuticals), and Electronics (semiconductor materials) with 62,000+ employees across 65 countries.
- Company typePublic
- Founded-
- HeadquartersDarmstadt, Germany
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What 默克雪兰诺有限公司 does
默克雪兰诺有限公司 is the Chinese operating subsidiary of Merck KGaA, Darmstadt, Germany, a German science and technology company founded in 1668 and headquartered in Darmstadt. The Chinese entity is registered in Beijing and operates as part of Merck KGaA's Healthcare business unit (branded as EMD Serono in the US/Canada and Merck Serono elsewhere), focusing on pharmaceutical therapies across oncology, neurology and immunology, fertility, and general medicine (cardiovascular, metabolism, endocrinology). Merck KGaA as a group operates three integrated business sectors: Life Science (branded MilliporeSigma), Healthcare, and Electronics (branded EMD Electronics), with global reach across 65 countries and 62,000+ employees.
The group's underlying technology portfolio includes the mRNA platform for vaccines and therapies, proprietary AI platforms AIDDISON™ (AI-powered drug design producing makeable molecules) and Synthia (AI tool predicting why 'perfect' molecules fail during development), and a broad Life Science toolkit covering Process Solutions, Advanced Solutions, Discovery Solutions, and BioReliance® release and stability testing services. Electronics capabilities include semiconductor thin films, optronics, formulations, metrology and inspection, specialty gases, delivery systems, and the Intermolecular® custom innovation brand. These technology assets underpin three distinct revenue streams: subscription/recurring Life Science tools and services, subscription/recurring Healthcare pharmaceutical products, and hardware-based Electronics materials and equipment sales.
Commercially, Merck KGaA runs a global enterprise field-sales model through wholly-owned subsidiary brands (MilliporeSigma, EMD Serono, EMD Electronics) supported by country-specific websites in 65 markets. Pricing is quote-based and not publicly disclosed, consistent with B2B enterprise and specialty pharmaceutical norms. The company is publicly listed on the Frankfurt Stock Exchange (ticker: MRK) and reported €20.2 billion in FY2023 revenue, with FY2025 guidance delivered in Q4 2025 press materials and a €25M BioReliance® testing facility opened in Darmstadt in July 2026. Open-innovation programs (Innovation Cup, Research Grants, Future Insight Prize) support external R&D pipeline development alongside internal Science Space research publication.
默克雪兰诺有限公司 firmographics
Firmographics- Name
- 默克雪兰诺有限公司
- Legal name
- Merck KGaA, Darmstadt, Germany
- Website
- https://merckserono.cn
- Company type
- Public
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Merck KGaA, Darmstadt, Germany (Chinese subsidiary: 默克雪兰诺有限公司) is a 1668-founded German science and technology company operating across Life Science (tools/services), Healthcare (pharmaceuticals), and Electronics (semiconductor materials) with 62,000+ employees across 65 countries.
- Ownership category
- akta.pro rank
默克雪兰诺有限公司 industry classification
Industry- Product category
- Pharmaceuticals and Life Sciences
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)
- akta.pro secondary industries
- Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors) (HLAAAJAC), Material Characterization & Spectroscopy (NMR/FTIR/MS) (HLAGADAK), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG), Manufacturing Quality, GMP Inspections & Compliance (HLAJADAG)
Keywords
Where 默克雪兰诺有限公司 is headquartered
LocationHeadquarters
- HQ city
- Darmstadt
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
默克雪兰诺有限公司 business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Healthcare Products: Pharmaceutical products including oncology drugs, neurology and immunology treatments, fertility therapies, and general medicine products sold to healthcare providers and patients globally
- Life Science Tools and Services: Process Solutions, Advanced Solutions, and Discovery Solutions providing tools, services and expertise for researchers and biopharma companies
- Electronics Materials and Equipment: Semiconductor materials including thin films, specialty gases, formulations, delivery systems, metrology and inspection services for electronics manufacturers
Go-to-market motion2 records
Distribution channels5 records
Marketing channels10 records
默克雪兰诺有限公司 product offering
Product offeringCore offering
Merck KGaA, Darmstadt, Germany operates through three business units. Life Science (MilliporeSigma) supplies Process Solutions, Advanced Solutions, Discovery Solutions, and BioReliance® biosafety testing services to researchers and biopharmaceutical manufacturers. Healthcare (EMD Serono) develops and commercializes prescription pharmaceuticals in Oncology, Neurology & Immunology, Fertility, and Cardiovascular/Metabolic diseases. Electronics (EMD Electronics) provides high-purity Thin Films, Optronics, Formulations, and Specialty Gases for semiconductor and display manufacturers.
Product overview
Merck KGaA, Darmstadt, Germany operates as a diversified science and technology company with three main business units organized under subsidiary brands. In the United States and Canada, the company uses MilliporeSigma for Life Science, EMD Serono for Healthcare, and EMD Electronics for Electronics. The Life Science business provides Process Solutions, Advanced Solutions, and Discovery Solutions, including BioReliance® testing services. The Healthcare business focuses on Oncology, Neurology & Immunology, Fertility, and Cardiovascular/Metabolism/Endocrinology therapeutic areas, supported by the Vibrant Thoughts blog. The Electronics business offers semiconductor technologies including Thin Films, Optronics, Formulations, Metrology and Inspection, Delivery Systems & Services, Specialty Gases, and the Intermolecular® brand for custom innovation. The company also develops AI-powered tools including Synthia for molecular failure prediction and AIDDISON™ for AI-driven drug design. Research operations include Open Innovation programs (Innovation Cup, Research Grants, Future Insight Prize), AI Research, and Clinical Trials capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- MilliporeSigma: Life science business of Merck KGaA, providing process solutions, advanced solutions, and discovery solutions
- EMD Serono
- EMD Electronics
- EMD (US/Canada umbrella)
Products and services
- Process Solutions (Life Science / MilliporeSigma) Bioprocessing products and services that support biopharmaceutical manufacturing, including filtration, chromatography, raw materials, and process-development tools, sold to biopharma manufacturers and CDMOs.
- Advanced Solutions (Life Science / MilliporeSigma) Products and services supporting cell and gene therapies, gene editing, and advanced biologics development, sold to cell-therapy developers, CDMOs, and research institutions.
- Discovery Solutions (Life Science / MilliporeSigma) Lab consumables, reagents, instruments, and software used by researchers in drug discovery, sold to pharmaceutical companies, academic institutes, and contract research organizations.
- BioReliance® Testing Services Contract biosafety, sterility, viral-clearance, and lot-release testing services for biologics, vaccines, and cell therapies, sold to biopharma manufacturers requiring GMP-compliant testing.
- Oncology Therapeutics (Healthcare / EMD Serono) Prescription drugs used to treat oncological diseases, sold through healthcare providers, hospitals, and specialty pharmacies.
- Neurology & Immunology Therapeutics (Healthcare / EMD Serono) Prescription drugs used to treat neurological and immunological diseases including multiple sclerosis, sold through healthcare providers, hospitals, and specialty pharmacies.
- Fertility Therapeutics (Healthcare / EMD Serono) Drugs and hormone preparations used in assisted reproductive technology and fertility treatment, sold through fertility clinics, hospitals, and specialty pharmacies.
- Cardiovascular and Metabolic Therapeutics (Healthcare / EMD Serono) Prescription drugs for cardiovascular and metabolic diseases, including type 2 diabetes treatments, sold through healthcare providers, hospitals, and pharmacies.
- Thin Films (Electronics / EMD Electronics) High-purity thin-film deposition materials used in semiconductor wafer fabrication and display manufacturing, sold to semiconductor fabs and display panel manufacturers.
- Optronics (Electronics / EMD Electronics) Materials and effects chemicals for optical and optoelectronic applications used in display and lighting manufacturing, sold to display panel makers and specialty OEMs.
- Formulations (Electronics / EMD Electronics) Custom-formulated chemical products for electronics manufacturing, including cleaning, etching, and surface-treatment chemistries, sold to semiconductor and electronics OEMs.
- Specialty Gases (Electronics / EMD Electronics) Ultra-high-purity specialty gases used in semiconductor etching, deposition, and chamber-clean processes, sold to semiconductor fabs and specialty gas distributors.
- AIDDISON™ AI Drug Design Platform Software platform using AI to virtually screen and design small-molecule drug candidates, sold or licensed to pharmaceutical and biotechnology companies to accelerate drug discovery.
- Synthia™ Retrosynthesis AI Software AI-based retrosynthesis planning software that suggests viable synthetic routes for organic molecules, sold or licensed to chemists in pharmaceutical, agrochemical, and specialty chemical companies.
Quantifiable outcome
- €25M BioReliance® facility expansion for biopharma testing services in Europe
Companies that use 默克雪兰诺有限公司
Customer profileSegments3 records
Ideal customer profiles3 records
默克雪兰诺有限公司 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature7 records
默克雪兰诺有限公司 partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
默克雪兰诺有限公司 competitors and assessment
Company assessmentBroad incumbents
- Roche Holding: Large pharmaceutical incumbent with overlapping therapeutic areas (oncology, neurology, immunology) and a diagnostics arm. Comparable as a broad life sciences peer, though Merck's life science tools and electronics businesses are not directly mirrored.
- DuPont de Nemours: Specialty materials company with semiconductor materials, electronics, and healthcare-adjacent offerings. Comparable to Merck's Electronics segment in thin films and electronic materials supply to chipmakers.
- BASF SE: German chemical giant with electronic materials, specialty chemicals, and life science adjacencies. Comparable as a broad German industrial/specialty chemicals incumbent with overlap in electronics materials.
- Novartis AG: Global pharma incumbent with overlapping therapeutic focus areas (neurology, immunology, oncology, cardiovascular). Comparable as a healthcare peer in scale and therapeutic portfolio, though without Merck's life science tools and electronics exposure.
- Sanofi: Diversified global pharmaceutical company with neurology/immunology (Dupixent), rare disease, and vaccines. Comparable on the Healthcare side; less overlap on life science tools and electronics materials.
Emerging players
- Shimadzu Corporation: Japanese analytical and measurement instruments maker (mass spectrometers, chromatography, lab equipment). Comparable to Merck's analytical instruments portfolio within the Life Science business unit.
Direct peers
- Agilent Technologies: Analytical laboratory instruments and life science/chemical analysis provider. Direct competitor to Merck's Discovery Solutions and analytical chemistry offerings across pharma, food, and environmental customers.
- Danaher Corporation: Diversified life science and diagnostics platform (Cytiva, Beckman Coulter, Leica, Pall, IDT). Directly comparable to Merck's Life Science unit across bioprocessing, life science instruments, and biopharma services.
- Lonza Group AG: Global CDMO/biomanufacturing services leader. Direct competitor to Merck's Process Solutions and BioReliance® testing services for biologics manufacturing customers.
- Thermo Fisher Scientific: The closest direct peer to Merck KGaA's Life Science business (MilliporeSigma). Both supply bioprocessing, analytical instruments, lab consumables, and biopharma services (e.g., Patheon/CDMO, PPD) to overlapping biopharma R&D and manufacturing customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
默克雪兰诺有限公司 social profiles
Digital presence默克雪兰诺有限公司 financial estimates
Financial estimateRevenue estimate
Valuation estimate
默克雪兰诺有限公司 leadership team
Management profileNumber of profiles
Profiles1 record
默克雪兰诺有限公司 subsidiaries and ownership
Company hierarchySubsidiaries3 records
默克雪兰诺有限公司 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
默克雪兰诺有限公司 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 默克雪兰诺有限公司
What does 默克雪兰诺有限公司 do?
Merck KGaA, Darmstadt, Germany operates through three business units. Life Science (MilliporeSigma) supplies Process Solutions, Advanced Solutions, Discovery Solutions, and BioReliance® biosafety testing services to researchers and biopharmaceutical manufacturers. Healthcare (EMD Serono) develops and commercializes prescription pharmaceuticals in Oncology, Neurology & Immunology, Fertility, and Cardiovascular/Metabolic diseases. Electronics (EMD Electronics) provides high-purity Thin Films, Optronics, Formulations, and Specialty Gases for semiconductor and display manufacturers.
Is 默克雪兰诺有限公司 a public or private company?
默克雪兰诺有限公司 is a public company. It is classified as public and is currently operating.
When was 默克雪兰诺有限公司 founded?
默克雪兰诺有限公司 was founded in -1. It employs 101 to 250 people.
Where is 默克雪兰诺有限公司 based?
默克雪兰诺有限公司 is headquartered in Darmstadt, Germany, in the Europe region.
How does 默克雪兰诺有限公司 make money?
Three revenue lines are on record. Healthcare Products are the primary driver. The others are life Science Tools and Services and electronics Materials and Equipment.
Who are 默克雪兰诺有限公司's main competitors?
Broad incumbents on record are Roche Holding, DuPont de Nemours, BASF SE, Novartis AG and Sanofi. Shimadzu Corporation is listed as an emerging player. Direct peers are Agilent Technologies, Danaher Corporation, Lonza Group AG and Thermo Fisher Scientific.
Does 默克雪兰诺有限公司 have an API?
No public API is recorded for 默克雪兰诺有限公司.
What industry is 默克雪兰诺有限公司 in?
默克雪兰诺有限公司's product category is Pharmaceuticals and Life Sciences. Its primary akta.pro industry code is HLAGAKAL, Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control), with a secondary code of HLAAAJAC, Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors). Its NAICS code is 325412 and its SIC code is 2834.